Central sleep apnea

Handbook of Clinical Neurology

Volumn 98, Issue C, 2011, Pages 411-419

  Pack, Allan I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOOK; CENTRAL SLEEP APNEA SYNDROME; HUMAN;

HUMANS; SLEEP APNEA, CENTRAL;

EID: 78149387185     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52006-7.00027-7     Document Type: Book

References (51)

1. American Academy of Sleep Medicine Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22(5):667-689.
2. Amiel J., Laudier B., Attie-Bitach T., et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 2003, 33(4):459-461.
3. Andreas S., Clemens C., Sandholzer H., et al. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996, 27(6):1486-1490.
4. Antic N.A., Malow B.A., Lange N., et al. PHOX2B mutation-confirmed congenital central hypoventilation syndrome: presentation in adulthood. Am J Respir Crit Care Med 2006, 174(8):923-927.
5. Arzt M., Floras J.S., Logan A.G., et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007, 115(25):3173-3180.
6. Bassetti C., Aldrich M.S., Quint D., et al. Sleep-disordered breathing in patients with acute supra- and infratentorial strokes. A prospective study of 39 patients. Stroke 1997, 28(9):1765-1772.
7. Bradley T.D., McNicholas W.T., Rutherford R., et al. Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis 1986, 134(2):217-221.
8. Bradley T.D., Logan A.G., Kimoff R.J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005, 353(19):2025-2033.
9. Bristow M.R., Gilbert E.M., Abraham W.T., et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996, 94(11):2807-2816.
10. Burgess K.R., Johnson P.L., Edwards N. Central and obstructive sleep apnoea during ascent to high altitude. Respirology 2004, 9(2):222-229.
11. Cheyne J. A case of apoplexy in which the fleshy part of the heart converted into fat 1818, Dublin Hospital Report.
12. Colucci W.S., Packer M., Bristow M.R., et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group [see comment]. Circulation 1996, 94(11):2800-2806.
13. DeBacker W.A., Verbraecken J., Willemen M., et al. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995, 151(1):87-91.
14. Eckert D.J., Jordan A.S., Merchia P., et al. Central sleep apnea: pathophysiology and treatment. Chest 2007, 131(2):595-607.
15. Franklin K.A., Eriksson P., Sahlin C., et al. Reversal of central sleep apnea with oxygen. Chest 1997, 111(1):163-169.
16. Hanly P.J., Millar T.W., Steljes D.G., et al. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989, 111(10):777-782.
17. Heistad D.D., Wheeler R.C., Mark A.L., et al. Effects of adrenergic stimulation on ventilation in man. J Clin Invest 1972, 51(6):1469-1475.
18. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006, 173(2):234-237.
19. Javaheri S., Parker T.J., Wexler L., et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996, 335(8):562-567.
20. Javaheri S., Parker T.J., Liming J.D., et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998, 97(21):2154-2159.
21. 2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999, 22(8):1101-1106.
22. Khoo M.C., Kronauer R.E., Strohl K.P., et al. Factors inducing periodic breathing in humans: a general model. J Appl Physiol 1982, 53(3):644-659.
23. Khoo M.C., Gottschalk A., Pack A.I. Sleep-induced periodic breathing and apnea: a theoretical study. J Appl Physiol 1991, 70(5):2014-2024.
24. Kohnlein T., Welte T. Does beta-blocker treatment influence central sleep apnoea?. Respir Med 2007, 101(4):850-853.
25. Krachman S.L., D'Alonzo G.E., Berger T.J., et al. Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 1999, 116(6):1550-1557.
26. Lanfranchi P.A., Braghiroli A., Bosimini E., et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999, 99(11):1435-1440.
27. Leung R.S., Huber M.A., Rogge T., et al. Association between atrial fibrillation and central sleep apnea. Sleep 2005, 28(12):1543-1546.
28. Lorenzi-Filho G., Rankin F., Bies I., et al. Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 1999, 159(5 Pt 1):1490-1498.
29. Morgenthaler T.I., Kagramanov V., Hanak V., et al. Complex sleep apnea syndrome: is it a unique clinical syndrome?. Sleep 2006, 29(9):1203-1209.
30. Morgenthaler T.I., Gay P.C., Gordon N., et al. Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep 2007, 30(4):468-475.
31. Nakayama H., Smith C.A., Rodman J.R., et al. Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am J Respir Crit Care Med 2002, 165(9):1251-1260.
32. Naughton M.T., Benard D.C., Liu P.P., et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995, 152(2):473-479.
33. Naughton M.T., Liu P.P., Bernard D.C., et al. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995, 151(1):92-97.
34. Oldenburg O., Lamp B., Faber L., et al. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007, 9(3):251-257.
35. Olson L.J., Somers V.K. Treating central sleep apnea in heart failure: outcomes revisited. Circulation 2007, 115(25):3140-3142.
36. Packer M., Coats A.J., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344(22):1651-1658.
37. Pepin J.L., Chouri-Pontarollo N., Tamisier R., et al. Cheyne-Stokes respiration with central sleep apnoea in chronic heart failure: proposals for a diagnostic and therapeutic strategy. Sleep Med Rev 2006, 10(1):33-47.
38. Pesek C.A., Cooley R., Narkiewicz K., et al. Theophylline therapy for near-fatal Cheyne-Stokes respiration. A case report [see comment]. Ann Intern Med 1999, 130(5):427-430.
39. Sin D.D., Fitzgerald F., Parker J.D., et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160(4):1101-1106.
40. Sin D.D., Logan A.G., Fitzgerald F.S., et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000, 102(1):61-66.
41. Skatrud J.B., Dempsey J.A. Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol 1983, 55(3):813-822.
42. Solin P., Bergin P., Richardson M., et al. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999, 99(12):1574-1579.
43. Stokes W. The Diseases of the Heart and Aorta 1854, Hodges & Smith, Dublin, Ireland.
44. Tamura A., Kawano Y., Naono S., et al. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 2007, 131(1):130-135.
45. Teschler H., Dohring J., Wang Y.M., et al. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001, 164(4):614-619.
46. Thomas R.J., Daly R.W., Weiss J.W. Low-concentration carbon dioxide is an effective adjunct to positive airway pressure in the treatment of refractory mixed central and obstructive sleep-disordered breathing. Sleep 2005, 28(1):69-77.
47. Tkacova R., Wang H., Bradley T.D. Night-to-night alterations in sleep apnea type in patients with heart failure. J Sleep Res 2006, 15(3):321-328.
48. Weese-Mayer D.E., Berry-Kravis E.M., Zhou L., et al. Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b. Am J Med Genet A 2003, 123(3):267-278.
49. Weese-Mayer D.E., Berry-Kravis E.M., Marazita M.L. In pursuit (and discovery) of a genetic basis for congenital central hypoventilation syndrome. Respir Physiol Neurobiol 2005, 149(1-3):73-82.
50. White D.P., Zwillich C.W., Pickett C.K., et al. Central sleep apnea. Improvement with acetazolamide therapy. Arch Intern Med 1982, 142(10):1816-1819.
51. 2 and added dead space on idiopathic central sleep apnea. J Appl Physiol 1997, 82(3):918-926.